Scott Braunstein - Net Worth and Insider Trading
Scott Braunstein Net Worth
The estimated net worth of Scott Braunstein is at least $294,153 dollars as of 2024-12-27. Scott Braunstein is the SVP, Strategy & Corp. Dev. of Pacira BioSciences Inc and owns about 9,982 shares of Pacira BioSciences Inc (PCRX) stock worth over $197,743. Scott Braunstein is also the CHAIRMAN AND CEO of Marinus Pharmaceuticals Inc and owns about 298,667 shares of Marinus Pharmaceuticals Inc (MRNS) stock worth over $96,410. Details can be seen in Scott Braunstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Braunstein has not made any transactions after 2024-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Braunstein
Scott Braunstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Braunstein owns 8 companies in total, including Protara Therapeutics Inc (TARA) , Constellation Pharmaceuticals Inc (CNST) , and Trevena Inc (TRVN) among others .
Click here to see the complete history of Scott Braunstein’s form 4 insider trades.
Insider Ownership Summary of Scott Braunstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARA | Protara Therapeutics Inc | 2020-01-09 | director |
| CNST | Constellation Pharmaceuticals Inc | 2020-06-04 | director |
| TRVN | Trevena Inc | 2022-06-09 | director |
 | | 2024-08-05 | director |
| | 2018-09-18 | director |
| | 2015-06-15 | director |
| | 2017-06-05 | SVP & Strategy & Corp. Dev. |
| | 2021-07-22 | director |
Scott Braunstein Latest Holdings Summary
Scott Braunstein currently owns a total of 2 stocks. Among these stocks, Scott Braunstein owns 9,982 shares of Pacira BioSciences Inc (PCRX) as of June 5, 2017, with a value of $197,743 and a weighting of 67.22%. Scott Braunstein also owns 298,667 shares of Marinus Pharmaceuticals Inc (MRNS) as of August 5, 2024, with a value of $96,410 and a weighting of 32.78%.
Latest Holdings of Scott Braunstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2017-06-05 | 9,982 | 19.81 | 197,743 |
| MRNS | Marinus Pharmaceuticals Inc | 2024-08-05 | 298,667 | 0.32 | 96,410 |
Holding Weightings of Scott Braunstein
Scott Braunstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Braunstein has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 768 shares on June 5, 2017, which brought Scott Braunstein around $33,270.
According to the SEC Form 4 filings, Scott Braunstein has made a total of 2 transactions in Marinus Pharmaceuticals Inc (MRNS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Marinus Pharmaceuticals Inc is the sale of 12,145 shares on August 5, 2024, which brought Scott Braunstein around $13,724.
Insider Trading History of Scott Braunstein
- 1
Scott Braunstein Trading Performance
GuruFocus tracks the stock performance after each of Scott Braunstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Braunstein is -6.63%. GuruFocus also compares Scott Braunstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Braunstein within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Braunstein's insider trading performs compared to the benchmark.
Performance of Scott Braunstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.2 | | | | | |
| Relative Return to S&P 500(%) | 7.52 | | | | | |
Scott Braunstein Ownership Network
Scott Braunstein Owned Company Details
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Scott Braunstein is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Scott Braunstein made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
Scott Braunstein Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Braunstein. You might contact Scott Braunstein via mailing address: C/o Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
